Corstasis Therapeutics Inc. ( a late clinical-stage innovator of therapies that enhance options for the treatment of fluid ...

J&J’s Innovative Medicine business continued its solid growth in the second quarter of 2025 with sales rising 4.9% year over ...

ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...

Revised Phase 2 Strategy Targets Event-Free Survival in Primary Head and Neck Cancer through Checkpoint Inhibitor Combination ...

Genascence’s GNSC-001 for knee osteoarthritis receives US FDA regenerative medicine advanced therapy designation: Palo Alto, California Saturday, July 19, 2025, 16:30 Hrs [IST] ...

“Some women in midlife experience these symptoms more intensely, potentially due to increased visceral sensitivity, changes ...

If you're looking for something other than aspirin to relieve a headache, experts say you should consider what's on your ...

With nearly half of all pregnancies worldwide being unintended, the need for effective, reversible male contraceptives ...

Mesoblast shares (ASX:MSB) experienced a dramatic surge today, closing at A$2.41, for a 34.64% gain on the day, having hit an intra-day high of A$2.48. This impressive jump followed the company's ...

Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...